(Q46895359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Vito Racanelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Eline Menu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Domenico Ribatti

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ruggiero Fumarulo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

M A Frassanito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

L Rao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

M Moschetta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

L Di Marzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A De Luisi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

I Catacchio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Berardi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A Basile

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Ruggieri

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B Nico

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

F Dammacco

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

K Vanderkerken

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

A Vacca

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

2 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

904-916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23995611%20AND%20SRC:MED&resulttype=core&format=json

Know thy neighbor: stromal cells can contribute oncogenic signals

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Tumor microenvironment: the role of the tumor stroma in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Stromal fibroblasts in cancer: a novel tumor-promoting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Cancer associated fibroblasts in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Stromal myofibroblasts are drivers of invasive cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

The myofibroblast: one function, multiple origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Mechanisms of force generation and transmission by myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Mechanotransduction through growth-factor shedding into the extracellular space

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Mechanics, malignancy, and metastasis: the force journey of a tumor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Bone marrow angiogenesis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Myeloma as a model for the process of metastasis: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Expression and function of chemokine receptors in human multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Regulation of endothelial cell plasticity by TGF-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

The history of the angiogenic switch concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Integrins as novel drug targets for overcoming innate drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Production of fibronectin and adherence to fibronectin by human myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.254

Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells

21 January 2018

1 reference

12 December 2020

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

1 reference

12 December 2020

Bone marrow angiogenesis and progression in multiple myeloma

1 reference

12 December 2020

Sturctural analysis of endocardial cytodifferentiation

1 reference

12 December 2020

On the origin of cancer-associated fibroblasts

1 reference

12 December 2020

Integrin-mediated drug resistance in multiple myeloma

1 reference

12 December 2020

Heterogeneity of stromal fibroblasts in tumors

1 reference

12 December 2020

Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny

1 reference

12 December 2020

Identification of fibroblast heterogeneity in the tumor microenvironment

1 reference

12 December 2020

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

1 reference

12 December 2020